Definitive Healthcare Net Worth

Definitive Healthcare Net Worth Breakdown

  DH
The net worth of Definitive Healthcare Corp is the difference between its total assets and liabilities. Definitive Healthcare's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Definitive Healthcare's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Definitive Healthcare's net worth can be used as a measure of its financial health and stability which can help investors to decide if Definitive Healthcare is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Definitive Healthcare Corp stock.

Definitive Healthcare Net Worth Analysis

Definitive Healthcare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Definitive Healthcare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Definitive Healthcare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Definitive Healthcare's net worth analysis. One common approach is to calculate Definitive Healthcare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Definitive Healthcare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Definitive Healthcare's net worth. This approach calculates the present value of Definitive Healthcare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Definitive Healthcare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Definitive Healthcare's net worth. This involves comparing Definitive Healthcare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Definitive Healthcare's net worth relative to its peers.

Enterprise Value

595.77 Million

To determine if Definitive Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Definitive Healthcare's net worth research are outlined below:
Definitive Healthcare generated a negative expected return over the last 90 days
Definitive Healthcare has high historical volatility and very poor performance
Definitive Healthcare has a very high chance of going through financial distress in the upcoming years
The company generated the yearly revenue of 252.2 M. Annual Net Loss to common stockholders was (591.45 M) with gross profit of 211.52 M.
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from thelincolnianonline.com: 287,409 Shares in Definitive Healthcare Corp. Purchased by Susquehanna Fundamental Investments LLC

Definitive Healthcare Quarterly Good Will

393.28 Million

Definitive Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Definitive Healthcare Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Definitive Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Definitive Healthcare's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Definitive Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Definitive Healthcare Corp backward and forwards among themselves. Definitive Healthcare's institutional investor refers to the entity that pools money to purchase Definitive Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Morgan Stanley - Brokerage Accounts2024-12-31
775.6 K
Millennium Management Llc2024-12-31
772.9 K
New York State Common Retirement Fund2024-12-31
771.8 K
D. E. Shaw & Co Lp2024-12-31
709.8 K
B. Riley Asset Management, Llc2024-12-31
677.9 K
Bank Of America Corp2024-12-31
617.5 K
Renaissance Technologies Corp2024-12-31
579.4 K
Citadel Advisors Llc2024-12-31
524.1 K
Northern Trust Corp2024-12-31
497.3 K
Advent International Lp2024-12-31
62.5 M
Irenic Capital Management Lp2024-12-31
M
Note, although Definitive Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Definitive Healthcare's market capitalization trends

The company currently falls under 'Small-Cap' category with a market capitalization of 306.61 M.

Market Cap

455.42 Million

Project Definitive Healthcare's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.04)(0.99)
Return On Capital Employed(0.77)(0.73)
Return On Assets(0.38)(0.36)
Return On Equity(0.93)(0.88)
The company has Net Profit Margin (PM) of (1.64) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.01 %, which signifies that for every $100 of sales, it has a net operating income of $0.01.
When accessing Definitive Healthcare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Definitive Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Definitive Healthcare's profitability and make more informed investment decisions.

Evaluate Definitive Healthcare's management efficiency

The Definitive Healthcare's current Return On Tangible Assets is estimated to increase to -0.99. The Definitive Healthcare's current Return On Capital Employed is estimated to increase to -0.73. As of now, Definitive Healthcare's Fixed Asset Turnover is decreasing as compared to previous years. The Definitive Healthcare's current Asset Turnover is estimated to increase to 0.24, while Net Tangible Assets are projected to decrease to (682 M). Definitive Healthcare's management efficiency ratios could be used to measure how well Definitive Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 5.21  4.95 
Tangible Book Value Per Share(0.72)(0.76)
Enterprise Value Over EBITDA(1.11)(1.05)
Price Book Value Ratio 1.08  1.02 
Enterprise Value Multiple(1.11)(1.05)
Price Fair Value 1.08  1.02 
Enterprise Value627.1 M595.8 M
Examining the leadership quality of Definitive Healthcare Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue
1.0688
Revenue
252.2 M
Quarterly Revenue Growth
(0.06)
Revenue Per Share
2.162
Return On Equity
(0.65)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Definitive Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Definitive Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Definitive Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Shamsuddin Kate Marie few days ago
Acquisition by Shamsuddin Kate Marie of 243446 shares of Definitive Healthcare subject to Rule 16b-3
 
Jason Krantz over a month ago
Acquisition by Jason Krantz of 153847 shares of Definitive Healthcare subject to Rule 16b-3
 
William Moschella over a month ago
Disposition of 6711 shares by William Moschella of Definitive Healthcare at 4.41 subject to Rule 16b-3
 
Richard Booth over a month ago
Disposition of 963 shares by Richard Booth of Definitive Healthcare at 2.59 subject to Rule 16b-3
 
Winters Kathleen A over a month ago
Acquisition by Winters Kathleen A of 26759 shares of Definitive Healthcare subject to Rule 16b-3
 
Jason Krantz over two months ago
Disposition of 7471 shares by Jason Krantz of Definitive Healthcare at 5.55 subject to Rule 16b-3
 
Richard Booth over three months ago
Disposition of 27080 shares by Richard Booth of Definitive Healthcare at 4.86 subject to Rule 16b-3
 
William Moschella over three months ago
Disposition of 13421 shares by William Moschella of Definitive Healthcare at 4.11 subject to Rule 16b-3
 
Richard Booth over three months ago
Disposition of 1501 shares by Richard Booth of Definitive Healthcare at 4.49 subject to Rule 16b-3
 
William Moschella over three months ago
Disposition of 45000 shares by William Moschella of Definitive Healthcare at 4.7 subject to Rule 16b-3
 
Richard Booth over three months ago
Acquisition by Richard Booth of 92379 shares of Definitive Healthcare subject to Rule 16b-3
 
Jason Krantz over six months ago
Disposition of 7830 shares by Jason Krantz of Definitive Healthcare at 4.18 subject to Rule 16b-3

Definitive Healthcare Corporate Filings

F4
29th of April 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
23rd of April 2025
Other Reports
ViewVerify
F3
4th of March 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
27th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
Definitive Healthcare time-series forecasting models is one of many Definitive Healthcare's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Definitive Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Definitive Healthcare Earnings per Share Projection vs Actual

Definitive Healthcare Corporate Management

Jon MaackPresidentProfile
Mary DelanoSenior SciencesProfile
Matt RudermanChief SecretaryProfile
David KronfeldChief OfficerProfile
Richard CPAChief OfficerProfile
Marissa OdellSenior DiversifiedProfile
Rebecca MaraniSenior ProviderProfile
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.54)
Revenue Per Share
2.162
Quarterly Revenue Growth
(0.06)
Return On Assets
(0)
Return On Equity
(0.65)
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.